Tyrone Brewer, Janssen US oncology president, and Frederick Anderson (Photo credit: Mark Krajnak of Janssen Oncology)
February 2, 2023 01:42 PM ESTUpdated February 6, 07:48 PM
Pharma
Marketing

J&J’s Janssen ‘Blue Jack­et’ fash­ion show re­turns to run­way for prostate can­cer aware­ness

Beth Snyder Bulik

Senior Editor

The an­nu­al “Blue Jack­et” Fash­ion Week run­way show is more than just show­ing off high-style looks for spon­sor John­son & John­son’s Janssen. It’s about turn­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Ky­owa Kirin ac­quires ex-US rights to Ku­ra’s leukemia treat­ment for $330M up­front

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times